Trial Information

Summary: Volunteers with Irritable Bowel Syndrome

This study is for female patients with diarrhea-predominant (loose stool) or alternating irritable bowel syndrome (one day loose stool and one day constipation.) The purpose of this study is to see how safe and effective 3 different doses of an investigational medication compared with placebo (an inactive substance) are when taken twice daily. The medication is experimental which means it has not been approved by the U.S. Food and Drug Administration (FDA). Eligible patients will receive study medication, study-related medical care and testing at no charge and may also be compensated for their travel expenses and time

To be eligible for the study patients must:

• Be female 18-65 years of age
• Have a history of IBS
• Have at least 3 bowel movements per week during the screening period

If you would like to learn more about participating in this study, please send an e-mail message using the form below.